Intrinsiqs

Is Encompass Health Corporation overvalued?

Encompass Health Corporation (EHC) looks overvalued — trading about 13% above its fair value.

Overvalued
Current price $123.91 Fair value $107.46
Price
$123.91
Fair value
$107.46
Current P/E
21.8
Normal P/E
18.9
Market cap
$12.29B
Dividend yield
0.6%
Return on equity
25.0%
Sector
Healthcare

See the full interactive analysis →

Fair value compares EHC's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 11 Aug 2026.

Related stocks

LLY Eli Lilly and CompanyJNJ Johnson & JohnsonABBV AbbVie Inc.RHHBY Roche Holding AGUNH UnitedHealth Group IncorporatedMRK Merck & Co., Inc.